PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Phenotype | C0087086|thrombi |
| Sentences | 7 |
| PubMedID- 20869094 | Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. |
| PubMedID- 24093164 | Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium. |
| PubMedID- 25639610 | Bile duct thrombi in hepatocellular carcinoma: is aggressive surgery worthwhile. |
| PubMedID- 21659784 | Background/aim: we previously reported the beneficial effects of a combination therapy of interferon (ifn)-alpha/5-fluorouracil (fu) for advanced hepatocellular carcinoma (hcc) with tumor thrombi in the major portal branches. |
| PubMedID- 23267901 | [a case of hepatocellular carcinoma with biliary tumor thrombi treated by extended hepatectomy]. |
| PubMedID- 21214943 | Background: to investigate the surgical outcome of hepatocellular carcinoma (hcc) patients with biliary tumor thrombi (btt). |
| PubMedID- 24367220 | Eligibility criteria were as follows: hepatocellular carcinoma with tumor thrombi invading at least one of the major branches of the portal vein (vp3 or vp4, according to the criteria of the liver cancer study group of japan [lcsgj]) or multiple intrahepatic metastases in more than three segments, irrespective of the degree of portal venous invasion (vp1, vp2, vp3, or vp4); tumor staging iii or iva based on the tnm (tumor node metastasis) staging system of the lcsgj; absence of extrahepatic metastases; child–pugh a or b liver function; an eastern cooperative oncology group (ecog) performance status of 0–1;22 leukocyte count >2000/μl; platelet count >50,000/μl; unresectable disease or not suitable for local ablation therapy; and unlikelihood of effectiveness with transcatheter arterial chemoembolization. |
Page: 1